L. Moist, L. Trpeski, Y. Na, and C. Lok, Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Registry 2001-2004, Clinical Journal of the American Society of Nephrology, vol.3, issue.6, pp.1726-1758, 2001.
DOI : 10.2215/CJN.01240308

M. Allon, Current Management of Vascular Access, Clinical Journal of the American Society of Nephrology, vol.2, issue.4, pp.786-800, 2007.
DOI : 10.2215/CJN.00860207

A. Schild, J. Prieto, M. Glenn, J. Livingstone, K. Alfieri et al., Maturation and Failure Rates in a Large Series of Arteriovenous Dialysis Access Fistulas, Vascular and Endovascular Surgery, vol.5, issue.5, pp.449-53, 2004.
DOI : 10.1016/S0895-7061(02)02261-6

L. Casserly and L. Dember, Thrombosis in End-Stage Renal Disease, Seminars in Dialysis, vol.114, issue.3, pp.245-56, 2003.
DOI : 10.1093/ndt/13.3.679

M. Noris and G. Remuzzi, Uremic bleeding: closing the circle after 30 years of controversies?, Blood, vol.94, pp.2569-74, 1999.

D. Kaw and D. Malhotra, HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End-Stage Renal Disease, Seminars in Dialysis, vol.2, issue.suppl 41, pp.317-339, 2006.
DOI : 10.1093/clinids/4.Supplement_3.S546

N. Deguchi, T. Ohigashi, H. Tazaki, M. Handa, and Y. Ikeda, Haemodialysis and platelet activation, Nephrol Dial Transplant, vol.6, issue.2, pp.40-42, 1991.

C. Coleman, L. Tuttle, C. Teevan, W. Baker, C. White et al., Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis, International Journal of Clinical Practice, vol.19, issue.9, pp.1239-1283, 2010.
DOI : 10.1111/j.1525-139X.2006.00218.x

B. Dixon, G. Beck, M. Vazquez, A. Greenberg, J. Delmez et al., Effect of Dipyridamole plus Aspirin on Hemodialysis Graft Patency, New England Journal of Medicine, vol.360, issue.21, pp.2191-201, 2009.
DOI : 10.1056/NEJMoa0805840

H. Trimarchi, P. Young, M. Forrester, J. Schropp, H. Pereyra et al., Clopidogrel Diminishes Hemodialysis Access Graft Thrombosis, Nephron Clinical Practice, vol.249, issue.3-4, pp.128-160, 2006.
DOI : 10.1016/S0140-6736(96)09457-3

L. Dember, G. Beck, M. Allon, J. Delmez, B. Dixon et al., Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis, JAMA, vol.299, issue.18, pp.2164-71, 2008.
DOI : 10.1001/jama.299.18.2164

J. Kaufman, O. Connor, T. Zhang, J. Cronin, R. Fiore et al., Randomized Controlled Trial of Clopidogrel plus Aspirin to Prevent Hemodialysis Access Graft Thrombosis, Journal of the American Society of Nephrology, vol.14, issue.9, pp.2313-2334, 2003.
DOI : 10.1097/01.ASN.0000081661.10246.33

L. Willms and L. Vercaigne, Review: Does Warfarin Safely Prevent Clotting of Hemodialysis Catheters?, Seminars in Dialysis, vol.4, issue.Suppl. 1, pp.71-78, 2008.
DOI : 10.1111/hdi.2000.4.1.37

L. Colì, G. Donati, G. Cianciolo, C. Raimondi, G. Comai et al., Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheter (TCC) thrombosis, The Journal of Vascular Access, vol.203, issue.1, pp.118-140, 2006.
DOI : 10.1148/radiology.203.2.9114110

H. Reinecke, E. Brand, R. Mesters, W. Schäbitz, M. Fisher et al., Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease, Journal of the American Society of Nephrology, vol.20, issue.4, pp.705-716, 2009.
DOI : 10.1681/ASN.2007111207

R. Pisters, D. Lane, R. Nieuwlaat, C. De-vos, H. Crijns et al., A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation, Chest, vol.138, issue.5, pp.1093-100, 2010.
DOI : 10.1378/chest.10-0134

D. Lane and G. Lip, Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation, Circulation, vol.126, issue.7, pp.860-865, 2012.
DOI : 10.1161/CIRCULATIONAHA.111.060061

S. Genovesi, D. Pogliani, A. Faini, M. Valsecchi, A. Riva et al., Prevalence of Atrial Fibrillation and Associated Factors in a Population of Long-Term Hemodialysis Patients, American Journal of Kidney Diseases, vol.46, issue.5, pp.897-902, 2005.
DOI : 10.1053/j.ajkd.2005.07.044

S. Khella and M. Bleicher, Stroke and Its Prevention in Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.2, issue.6, pp.1343-51, 2007.
DOI : 10.2215/CJN.04341206

C. Sánchez-perales, E. Vázquez, M. García-cortés, J. Borrego, M. Polaina et al., Ischaemic stroke in incident dialysis patients, Nephrology Dialysis Transplantation, vol.31, issue.9, pp.3343-3351, 2010.
DOI : 10.1161/01.STR.31.9.2080

S. Hiremath, R. Holden, D. Fergusson, and D. Zimmerman, Antiplatelet Medications in Hemodialysis Patients: A Systematic Review of Bleeding Rates, Clinical Journal of the American Society of Nephrology, vol.4, issue.8
DOI : 10.2215/CJN.00810209

H. Wasse, D. Gillen, A. Ball, B. Kestenbaum, S. Seliger et al., Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients, Kidney International, vol.64, issue.4, pp.1455-61, 2003.
DOI : 10.1046/j.1523-1755.2003.00225.x

URL : https://doi.org/10.1046/j.1523-1755.2003.00225.x

R. Holden, G. Harman, M. Wang, D. Holland, and A. Day, Major Bleeding in Hemodialysis Patients, Clinical Journal of the American Society of Nephrology, vol.3, issue.1, pp.105-115, 2008.
DOI : 10.2215/CJN.01810407

URL : http://cjasn.asnjournals.org/content/3/1/105.full.pdf

F. Knoll, G. Sturm, C. Lamina, E. Zitt, F. Lins et al., Coumarins and survival in incident dialysis patients, Nephrology Dialysis Transplantation, vol.140, issue.6, pp.332-339, 2012.
DOI : 10.1067/mhj.2000.111111

URL : https://academic.oup.com/ndt/article-pdf/27/1/332/6908313/gfr341.pdf

H. Feldman, S. Kobrin, and A. Wasserstein, Hemodialysis vascular access morbidity, J Am Soc Nephrol, vol.7, pp.523-558, 1996.

P. Best, S. Steinhubl, P. Berger, A. Dasgupta, D. Brennan et al., The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial, American Heart Journal, vol.155, issue.4, pp.687-93, 2008.
DOI : 10.1016/j.ahj.2007.10.046

A. Ishani, C. Herzog, A. Collins, and R. Foley, Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect?, Kidney International, vol.65, issue.3, pp.1017-1042, 2004.
DOI : 10.1111/j.1523-1755.2004.00473.x

K. Jurk and B. Kehrel, Platelets: Physiology and Biochemistry, Seminars in Thrombosis and Hemostasis, vol.31, issue.04, pp.381-92, 2005.
DOI : 10.1055/s-2005-916671

URL : http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2005-916671.pdf

A. Aggarwal, S. Kabbani, J. Rimmer, F. Gennari, D. Taatjes et al., Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular risk, American Journal of Kidney Diseases, vol.40, issue.2, pp.315-337, 2002.
DOI : 10.1053/ajkd.2002.34510

K. Fischer, Essentials of anticoagulation in hemodialysis, Hemodialysis International, vol.38, issue.7, pp.178-89, 2007.
DOI : 10.1046/j.1523-1755.1999.00671.x

D. Jager, D. Grootendorst, D. Jager, K. Van-dijk, P. Tomas et al., Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis, JAMA, vol.302, issue.16, pp.1782-1791, 1488.
DOI : 10.1001/jama.2009.1488

M. Sarnak and R. Foley, Cardiovascular Mortality in the General Population Versus Dialysis: A Glass Half Full or Empty?, American Journal of Kidney Diseases, vol.58, issue.1, pp.4-6, 2011.
DOI : 10.1053/j.ajkd.2011.04.004

J. Wright and A. Hutchison, Cardiovascular disease in patients with chronic kidney disease, Vasc Health Risk Manag, vol.5, pp.713-735, 2009.

S. Van-der-zee, U. Baber, S. Elmariah, J. Winston, and V. Fuster, Cardiovascular risk factors in patients with chronic kidney disease, Nature Reviews Cardiology, vol.44, issue.9, pp.580-589, 2009.
DOI : 10.7326/0003-4819-138-2-200301210-00010

J. Wetmore and T. Shireman, The ABCs of Cardioprotection in Dialysis Patients: A Systematic Review, American Journal of Kidney Diseases, vol.53, issue.3, pp.457-66, 2009.
DOI : 10.1053/j.ajkd.2008.07.037

S. Johnson, K. Rogers, T. Delate, and D. Witt, Outcomes Associated With Combined Antiplatelet and Anticoagulant Therapy, Chest, vol.133, issue.4, pp.948-54, 2008.
DOI : 10.1378/chest.07-2627

K. Chan, J. Lazarus, R. Thadhani, and R. Hakim, Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients, Journal of the American Society of Nephrology, vol.20, issue.4, pp.872-81, 2009.
DOI : 10.1681/ASN.2008080824

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663838/pdf

K. Chan, J. Lazarus, R. Thadhani, and R. Hakim, Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation, Journal of the American Society of Nephrology, vol.20, issue.10, pp.2223-2256, 2009.
DOI : 10.1681/ASN.2009030319